
COVID-19 RESOURCES
Refer to this page for the latest educational resources and information on lenzilumab as a therapeutic for cytokine storm resulting from COVID-19 infection.
Visit StopStorm.com To learn about Humanigen's Phase 3 Clinical Trial
Learn how Lenzilumab™ may reduce serious or fatal outcomes in COVID-19 patients